TIDMAMS
RNS Number : 3734U
Advanced Medical Solutions Grp PLC
27 March 2023
27 March 2023
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the world-leading specialist in tissue-healing technologies,
announces that it was notified on 23 March 2023 that on the same
day Chris Meredith, who is a Director and PDMR, had sold 35,900
Ordinary Shares of 5p held on his behalf and 8,200 Ordinary Shares
of 5p held on behalf of Ingrid Meredith, a PCA of Chris Meredith,
both in the name of Platform Securities Nominees Limited
("Nominee"), at a price of 225.5p per Ordinary Share.
On the same day, the Company was also informed that at the same
time Individual Savings Accounts ("ISA's") held in the name of
Chris Meredith purchased 8,800 Ordinary Shares of 5p, ISA's held in
the name of Ingrid Meredith purchased 8,200 Ordinary Shares of 5p,
ISA's in the name of Chris Meredith's PCA's purchased 22,700
Ordinary Shares of 5p and that Lifetime Individual Savings Accounts
("LISA's") held in the name of Chris Meredith's PCA's purchased
4,400 Ordinary Shares of 5p, all at a price of 225.6p per Ordinary
Share.
The number of shares, and the beneficial ownership of the
shares, held by Chris Meredith, Ingrid Meredith and his PCA's
remains unchanged. These transactions are part of normalised tax
planning.
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv)
each place where transactions have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
---------------------------------------------------------------------
Identification code: GB0004536594
b) Nature of the transactions:
* Sale of 8,800 Ordinary Shares of 5p held in the name
of the Nominee
* Purchase of 8,800 Ordinary Shares of 5p into ISA's
held in the name of Chris Meredith
----------------------------------------------------------------------
c) Price(s) and volume(s): Sale of shares:
Price(s) Volume(s)
------------------------------------------------- ----------------
Sale of shares from Nominee
holding at 225.5p per share 8,800
------------------------------------------------------ ----------------
Purchase by ISA's at 225.6p
per share 8,800
------------------------------------------------------ ----------------
d) Aggregated information: (Relates to those shares sold
only) Aggregated volume: 8,800
Aggregated price: 225.5p
----------------------------------------------------------------------
e) Date of the transaction: 23/03/2023
----------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM Market
(XLON)
----------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv)
each place where transactions have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Sale of 22,700 Ordinary Shares of 5p held in the name
of the Nominee
---------------------------------------------------------------------
* Purchase of 22,700 Ordinary Shares of 5p into ISA's
held in the name of Chris Meredith's PCA's
c) Price(s) and volume(s): Sale of shares:
Price(s) Volume(s)
------------------------------------------------ ----------------
Sale of shares from Nominee
holding at 225.5p per share 22,700
----------------------------------------------------- ----------------
Purchase by ISA's at 225.6p
per share 22,700
----------------------------------------------------- ----------------
d) Aggregated information: (Relates to those shares sold
only) Aggregated volume: 22,700
Aggregated price: 225.5p
---------------------------------------------------------------------
e) Date of the transaction: 23/03/2023
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM Market
(XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv)
each place where transactions have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Sale of 4,400 Ordinary Shares of 5p held in the name
of the Nominee
* Purchase of 4,400 Ordinary Shares of 5p into a LISA's
held in the name of Chris Meredith's PCA's
---------------------------------------------------------------------
c) Price(s) and volume(s): Sale of shares:
Price(s) Volume(s)
---------------------------------------------- ---------------
Sale of shares from Nominee
holding at 225.5p per share 4,400
--------------------------------------------------- ---------------
Purchase by LISA's at 225.6p
per share 4,400
--------------------------------------------------- ---------------
d) Aggregated information: (Relates to those shares sold
only) Aggregated volume: 4,400
Aggregated price: 225.5p
------------------------------------------------------------------
e) Date of the transaction: 23/03/2023
------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM Market
(XLON)
------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Ingrid Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: PCA to Chris Meredith, Director
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv)
each place where transactions have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Sale of 8,200 Ordinary Shares of 5p held in the name
of the Ingrid Meredith
* Purchase of 8,200 Ordinary Shares of 5p into ISA's
held in the name of Ingrid Meredith
---------------------------------------------------------------------
c) Price(s) and volume(s): Sale of shares:
---------------------------------------------------------------------
Price(s) Volume(s)
Sale of shares from Nominee
holding at 225.5p per share 8,200
--------------------------------------------------- ---------------
Purchase by ISA's at 225.6p
per share 8,200
--------------------------------------------------- ---------------
d) Aggregated information: (Relates to those shares sold
only) Aggregated volume: 8,200
Aggregated price: 225.5p
------------------------------------------------------------------
e) Date of the transaction: 23/03/2023
------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM Market
(XLON)
------------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer Michael King, Investor
Relations
Consilium Strategic Communications Tel: +44 (0) 20 3709 5700
Matthew Neal / Lucy Featherstone AMS@consilium-comms.com
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597 5970
Gary Clarence / David Anderson
HSBC Bank PLC (Broker) Tel: 44 (0) 20 7991 8888
Sam McLennan / Joe Weaving / Stephanie Cornish
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative tissue-healing technology, focused on quality outcomes
for patients and value for payers. AMS has a wide range of surgical
products including tissue adhesives, sutures, haemostats, internal
fixation devices and internal sealants, which it markets under its
brands LiquiBand(R) , RESORBA(R) , LiquiBandFix8(R) and Seal-G(R) .
AMS also supplies wound care dressings such as silver alginates,
alginates and foams through its ActivHeal(R) brand as well as under
white label. Since 2019, the Group has made five acquisitions:
Sealantis, an Israeli developer of innovative internal sealants;
Biomatlante, a French developer and manufacturer of surgical
biomaterials, Raleigh, a leading UK coater and converter of
woundcare and bio-diagnostics materials, AFS Medical, an Austrian
specialist surgical business and Connexicon, an Irish tissue
adhesives specialist.
AMS's products, manufactured in the UK, Germany, France, the
Netherlands, the Czech Republic and Israel, are sold globally via a
network of multinational or regional partners and distributors, as
well as via AMS's own direct sales forces in the UK, Germany, the
Czech Republic and Russia. The Group has
R&D innovation hubs in the UK, Ireland, Germany, France and
Israel. Established in 1991, the Group has more than 800 employees.
For more information, please see www.admedsol.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFERVSIDFIV
(END) Dow Jones Newswires
March 27, 2023 12:56 ET (16:56 GMT)
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
